IC
ENTA icon

IEQ Capital’s Enanta Pharmaceuticals ENTA Stock Holding History

IEQ Capital’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$561K Sell
38,508
-164
-0.4% -$2.2K ﹤0.01% 1348
2026
Q1 		$488K Buy
38,672
+2,287
+6% +$30.7K ﹤0.01% 1318
2025
Q4 		$574K Sell
36,385
-1,301
-3% -$16.5K ﹤0.01% 1268
2025
Q3 		$451K Sell
37,686
-2,662
-7% -$21.3K ﹤0.01% 1346
2025
Q2 		$305K Sell
40,348
-1,649
-4% -$9.92K ﹤0.01% 1383
2025
Q1 		$232K Buy
+41,997
New +$259K ﹤0.01% 1302

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

IEQ Capital's ENTA Position: Q2 2026 in Review

IEQ Capital reduced its Enanta Pharmaceuticals (ENTA) stake by 0.42% in Q2 2026, selling an estimated $2.2K and leaving 38,508 shares worth $561K. The position accounts for ﹤0.01% of the portfolio, ranked #1348.

IEQ Capital first reported a position in ENTA in Q1 2025 and has held it in 6 quarters since. The position peaked at $574K in Q4 2025. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • IEQ Capital held 38,508 shares of Enanta Pharmaceuticals worth $561K as of Q2 2026.
  • IEQ Capital sold 164 Enanta Pharmaceuticals shares in Q2 2026, an estimated $2.2K.
  • Enanta Pharmaceuticals made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1348 holding.
  • IEQ Capital first reported a position in Enanta Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Enanta Pharmaceuticals position peaked at $574K in Q4 2025.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.